In the last trading session, 3.25 million shares of the Oragenics Inc (AMEX:OGEN) were traded, and its beta was 0.85. Most recently the company’s share price was $0.26, and it changed around -$0.02 or -9.26% from the last close, which brings the market valuation of the company to $3.25M. OGEN currently trades at a discount to its 52-week high of $4.00, offering almost -1438.46% off that amount. The share price’s 52-week low was $0.25, which indicates that the current value has risen by an impressive 3.85% since then. We note from Oragenics Inc’s average daily trading volume that its 10-day average is 27.38 million shares, with the 3-month average coming to 5.26 million.
Oragenics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended OGEN as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Oragenics Inc is expected to report earnings per share of 0 for the current quarter.
Oragenics Inc (AMEX:OGEN) trade information
Instantly OGEN has showed a red trend with a performance of -9.26% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6299 on recent trading dayincreased the stock’s daily price by 58.72%. The company’s shares are currently down -29.98% year-to-date, but still down -16.31% over the last five days. On the other hand, Oragenics Inc (AMEX:OGEN) is -31.04% down in the 30-day period. We can see from the shorts that 0.19 million shares have been sold at a short interest cover period of 0.43 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 29.34%.
OGEN Dividends
Oragenics Inc’s next quarterly earnings report is expected to be released in March.
Oragenics Inc (AMEX:OGEN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 25.41% of Oragenics Inc shares, and 11.13% of them are in the hands of institutional investors. The stock currently has a share float of 14.92%.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 29.56 shares worth $7644.0, making up 0.24% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 8.87 shares worth around $2292.0, which represents about 0.07% of the total shares outstanding.
